Skip to main content
. 2018 Oct 31;120(1):57–62. doi: 10.1038/s41416-018-0234-3

Fig. 1.

Fig. 1

Kaplan–Meier analysis of progression-free survival (PFS) in NSCLC patients according to the KRAS-mutation status